Whalegun
Home

Mark Jason Heath Ellison, Chief Development Officer: Opiant Pharmaceuticals OPNT Sell · Filed 23/01/09

Trade details

Type
Insider sale
Amount
$9,473.8
Shares · price
469 sh · $20.20 a share
Held after
19,361 sh
Stock
Opiant Pharmaceuticals OPNT
Person
Mark Jason Heath EllisonChief Development Officer
Trade date
23/01/09
Filed
23/01/09
Days to filing
0 days

Sold 2.4% of holdings

Share of holding sold
2.4%

Opiant Pharmaceuticals trades, last 26 weeks

What else happened in Opiant Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/10~23/02/08

Mark Jason Heath Ellison's recent trades

  • Mark Jason Heath Ellison

    SellOpiant Pharmaceuticals

    $12.4K

    Filed 23/01/31

  • Mark Jason Heath Ellison

    SellOpiant Pharmaceuticals

    $36.5K

    Filed 23/01/05

Mark Jason Heath Ellison, Chief Officer — sold $9,474 of Opiant Pharmaceuticals OPNT · 2.4% of holdings | Whalegun